Revolution Medicines, Inc.
RVMD
$99.00
$4.144.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.52% | 24.66% | 34.35% | 23.43% | 23.55% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 28.76% | 55.04% | 15.44% | 24.34% | 52.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.85% | 25.23% | 33.96% | 23.44% | 23.86% |
|
|
|||||
| Total Current Assets | -10.85% | 25.23% | 33.96% | 23.44% | 23.86% |
| Net Property, Plant & Equipment | 16.54% | 68.81% | 46.19% | 43.09% | 41.80% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.54% | -1.88% | -1.87% | -1.86% | -1.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 149.23% | 177.88% | 212.57% | 134.08% | 74.58% |
| Total Assets | -7.97% | 27.73% | 34.35% | 23.95% | 24.09% |
|
|
|||||
| Total Accounts Payable | 18.72% | 206.06% | 93.60% | 46.72% | -11.91% |
| Total Accrued Expenses | 109.81% | 90.54% | 70.42% | 85.89% | 35.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.94% | 94.45% | 57.08% | 58.88% | 74.68% |
| Total Finance Division Other Current Liabilities | 1,247.86% | 544.84% | -29.68% | -12.50% | -85.04% |
| Total Other Current Liabilities | 1,247.86% | 544.84% | -29.68% | -12.50% | -85.04% |
| Total Current Liabilities | 77.18% | 121.55% | 75.19% | 69.22% | 13.95% |
|
|
|||||
| Total Current Liabilities | 77.18% | 121.55% | 75.19% | 69.22% | 13.95% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.66% | 81.50% | 51.37% | 51.97% | 52.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 255.88% | 42.91% | 4,920.59% | -22.24% | -43.96% |
| Total Liabilities | 146.75% | 233.01% | 197.59% | 57.03% | 24.45% |
|
|
|||||
| Common Stock & APIC | 12.38% | 31.95% | 35.09% | 35.14% | 35.04% |
| Retained Earnings | -65.10% | -62.27% | -58.55% | -55.64% | -52.75% |
| Treasury Stock & Other | 145.04% | -18.26% | 169.89% | 242.49% | 142.83% |
| Total Common Equity | -27.98% | 1.95% | 15.23% | 20.44% | 24.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.98% | 1.95% | 15.23% | 20.44% | 24.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.98% | 1.95% | 15.23% | 20.44% | 24.04% |
|
|
|||||